RECURSION PHARMACEUTICALS IN

Ticker: RXRX CUSIP: 75629V104 Class: Common Stock

Wedmont Private Capital's Holding History (CIK: 0001904274)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 18,943 Value ($000) $92 Avg Close $4.95 Range $3.81 - $7.18
Q3 2025
Shares 20,943 Value ($000) $110 Avg Close $5.25 Range $4.45 - $7.15
Q2 2025
Shares 20,943 Value ($000) $117 Avg Close $4.91 Range $3.79 - $6.11
Q1 2025
Shares 20,943 Value ($000) $121 Avg Close $7.29 Range $5.19 - $12.36
Q4 2024
Shares 20,943 Value ($000) $144 Avg Close $6.72 Range $5.60 - $9.55
Q3 2024
Shares 18,943 Value ($000) $117 Avg Close $7.17 Range $5.88 - $8.73
Q2 2024
Shares 18,943 Value ($000) $158 Avg Close $8.72 Range $6.75 - $10.66
Q1 2024
Shares 18,943 Value ($000) $172 Avg Close $11.14 Range $8.68 - $15.74
Q4 2023
Shares 16,943 Value ($000) $214 Avg Close $7.13 Range $4.97 - $11.17
Q3 2023
Shares 16,943 Value ($000) $115 Avg Close $9.98 Range $6.44 - $16.75
Q2 2023
Shares 16,943 Value ($000) $202 Avg Close $7.00 Range $4.54 - $10.45